Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group
Study Details
Study Description
Brief Summary
A double-blind, prospective, randomized, intra-individual comparative, single-center clinical study was conducted. Participants were placed in parallel groups, and the study was performed in the Department of Operative Dentistry and Periodontology, Dental School and Hospital, Minia university to compare the antibacterial activity of yarrow Moringa herbal combinations nanoparticles in compared to Chlorhexidine as a potential treatment for gingivitis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention group Bucco-adhesive films with Yarrow and Moringa extract nanoparticles |
Drug: Yarrow and moringa mixture
yarrow and moringa mixture nano particles loaded on buccal film
|
Active Comparator: control group Cholorohexiden oral gargles |
Drug: Yarrow and moringa mixture
yarrow and moringa mixture nano particles loaded on buccal film
|
Outcome Measures
Primary Outcome Measures
- antibacterial and anti inflammatory activities [two weeks]
scoring of erthymia and pain (no pain=0) and the other end (worst pain=10).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
a minimum of four natural uncrowned teeth in one quadrant present
-
good general health
-
can follow instructions
Exclusion Criteria:
-
were pregnant or breastfeeding
-
evidence of antibiotic use during the 4 weeks prior to the study
-
were allergic to personal care/consumer products or their ingredients
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Soad A. Mohamad | Minya | المنيا | Egypt | 05673 |
Sponsors and Collaborators
- Deraya University
Investigators
- Study Director: soad ali, PhD, faculty of pharmacy, Deraya university
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 3/23